by University of California, Los Angeles The study included a complementary translational approach with both preclinical in vitro studies and clinical studies using accessible PBMCs from HIV-1(−) participants (men and women) and people with HIV (PWH) with suppressed plasma viremia on TAF-based versus TDF-based ART. Credit: Theodoros Kelesidis New UCLA-led research suggests that antiretroviral drugs called TAF...